Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

BACKGROUND: Therapy for Type 2 diabetes (T2D) has been transformed by the introduction of newer agents like Glucagon like Peptide Receptor Agonists (GLP-1RA) and Sodium-glucose linked transporter inhibitors (SGLT2i). However with co-initiation of SGLT2i and GLP-1RA in the DURATION 8 trial an improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosal, S., Sinha, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941332/
https://www.ncbi.nlm.nih.gov/pubmed/29760945
http://dx.doi.org/10.1186/s40842-018-0061-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941332/
https://www.ncbi.nlm.nih.gov/pubmed/29760945
http://dx.doi.org/10.1186/s40842-018-0061-8

Ejemplares similares